PAPOTTI, Mauro Giulio
 Distribuzione geografica
Continente #
NA - Nord America 20808
EU - Europa 15421
AS - Asia 7431
SA - Sud America 500
OC - Oceania 249
AF - Africa 190
Continente sconosciuto - Info sul continente non disponibili 32
Totale 44631
Nazione #
US - Stati Uniti d'America 20099
CN - Cina 4271
IT - Italia 3347
IE - Irlanda 1743
DE - Germania 1665
FR - Francia 1431
SE - Svezia 1404
UA - Ucraina 1252
FI - Finlandia 908
KR - Corea 907
GB - Regno Unito 880
CA - Canada 594
AT - Austria 582
PL - Polonia 578
JP - Giappone 540
VN - Vietnam 435
IN - India 394
ES - Italia 305
BR - Brasile 293
TR - Turchia 257
AU - Australia 225
NL - Olanda 222
DK - Danimarca 209
BE - Belgio 159
RU - Federazione Russa 133
GR - Grecia 126
TW - Taiwan 104
MX - Messico 100
CH - Svizzera 98
HK - Hong Kong 95
AR - Argentina 86
SN - Senegal 84
RO - Romania 77
PT - Portogallo 68
ID - Indonesia 47
IL - Israele 47
CO - Colombia 46
NO - Norvegia 46
SG - Singapore 45
SA - Arabia Saudita 43
CZ - Repubblica Ceca 41
PH - Filippine 41
CL - Cile 35
PK - Pakistan 34
TH - Thailandia 34
HU - Ungheria 32
EU - Europa 31
MY - Malesia 30
UZ - Uzbekistan 30
RS - Serbia 24
ZA - Sudafrica 24
HR - Croazia 23
NZ - Nuova Zelanda 23
SI - Slovenia 21
DZ - Algeria 19
EG - Egitto 18
IR - Iran 17
EC - Ecuador 15
MU - Mauritius 13
PE - Perù 13
SK - Slovacchia (Repubblica Slovacca) 11
BG - Bulgaria 9
MA - Marocco 9
BY - Bielorussia 8
IQ - Iraq 8
JO - Giordania 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 5
MK - Macedonia 5
PR - Porto Rico 5
SC - Seychelles 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
LU - Lussemburgo 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
SD - Sudan 4
TN - Tunisia 4
BD - Bangladesh 3
GE - Georgia 3
GT - Guatemala 3
LB - Libano 3
LK - Sri Lanka 3
PA - Panama 3
CU - Cuba 2
KW - Kuwait 2
LV - Lettonia 2
MT - Malta 2
RE - Reunion 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BW - Botswana 1
CR - Costa Rica 1
ET - Etiopia 1
GH - Ghana 1
KE - Kenya 1
KG - Kirghizistan 1
Totale 44617
Città #
Beijing 2514
Chandler 2507
Houston 1728
Dublin 1719
Fairfield 1438
Ann Arbor 1088
Torino 923
Wilmington 867
Jacksonville 813
Redwood City 799
Villeurbanne 749
Woodbridge 740
Ashburn 659
Medford 595
Seattle 592
Princeton 575
Vienna 554
Cambridge 509
Dearborn 486
Warsaw 468
Nyköping 432
Pisa 415
Fremont 325
Boston 269
Milan 256
Dong Ket 226
Shanghai 212
Boardman 186
Toronto 163
Guangzhou 150
Nanjing 150
Tokyo 146
Verona 142
Hangzhou 131
Munich 116
Seoul 106
Norwalk 104
San Diego 96
New York 93
Düsseldorf 91
Montréal 90
Chicago 85
Brussels 81
Turin 77
Falls Church 74
Chengdu 73
Hefei 67
Lachine 66
Zhengzhou 65
Phoenix 64
Mcallen 63
Mountain View 62
Taipei 62
Wuhan 61
Würzburg 61
Ottawa 56
Shenyang 56
Bologna 55
Madrid 55
São Paulo 54
Silver Spring 53
Rome 52
Jinan 51
Kunming 51
Paris 49
Pittsburgh 49
Central District 47
Changsha 45
Tappahannock 45
London 44
Hebei 42
Istanbul 41
New Delhi 40
Rochester 40
Ankara 38
Bethesda 37
Canberra 37
Athens 36
Buenos Aires 36
Dallas 36
Honolulu 34
Lexington 34
Nanchang 34
Piemonte 34
Barcelona 31
Chongqing 31
Amsterdam 30
Detroit 30
Lyon 29
Santiago 28
Xian 28
Buffalo 27
Philadelphia 27
Brisbane 26
Calgary 26
Mexico 26
Oslo 26
Padova 26
Cleveland 25
Osaka 25
Totale 26905
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1301
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 922
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 800
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 760
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 657
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? 548
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 538
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 529
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 425
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied 422
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 396
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 368
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 350
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 328
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 327
Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review 323
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 318
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 317
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index - Which is the best predictor of prostate cancer after a negative biopsy? 314
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 303
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors 303
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas 295
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 293
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 279
Core biopsies of renal masses: a safe and accurate tool for managing all that is indeterminate 272
Mesothelioma families without inheritance of a BAP1 predisposing mutation 271
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing 270
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 269
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 265
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 264
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 262
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations 262
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 261
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 260
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. 242
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 241
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 238
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 237
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 236
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 219
An international Ki67 reproducibility study in adrenal cortical Carcinoma 219
Morgana is a new oncosuppressor in CML 215
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 214
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 214
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 211
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 209
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 204
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 203
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 202
Adjuvant mitotane treatment for adrenocortical carcinoma 199
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 198
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy 196
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 183
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 182
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 181
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 179
Differentiation-inducing factor 1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and Thymidylate Synthase mRNAs accumulation 176
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 171
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 170
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 170
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines 169
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. 165
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 164
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 162
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 161
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 160
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 158
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 156
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 156
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 153
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 151
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 148
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 147
Impact of COVID-19 lockdown measures on oncological surgical activity: Analysis of the surgical pathology caseload of a tertiary referral hospital in Northwestern Italy 146
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 145
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 144
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 142
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 141
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 139
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 139
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 138
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 137
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal 136
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 131
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract 127
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. 125
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. 123
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 123
Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era 123
Classification of pulmonary neuroendocrine tumors: New insights 123
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 121
mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. 120
Current state-of-the-art therapy for advanced squamous cell lung cancer 117
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 115
Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer 111
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 110
Thymidylate synthase expression in large cell carcinoma ofthe lung 109
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 109
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 109
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 103
Totale 24837
Categoria #
all - tutte 69798
article - articoli 0
book - libri 0
conference - conferenze 5114
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20184905 0000 00 01255 19761134271269
2018/20195836 371257416264 359461 326719 3355361203589
2019/20208846 448444593938 7461437 998650 854708614416
2020/20216672 576454582389 589495 607376 670627490817
2021/20226618 337377374476 358348 482411 28846713291371
2022/20236582 921627224884 8512256 8127 0000
Totale 46453